SCHEMBL8831999

SCHEMBL8831999

Cn1c2ccccc2c2nc3c(C=O)cccc3nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ LMNA P02545 3/20 0.50
▸ KMT2A Q03164 5/20 0.48
▸ MEN1 O00255 4/20 0.48
▸ NR1I2 O75469 1/20 0.48
▸ AHR P35869 1/20 0.48
▸ MAPT P10636 5/20 0.47
▸ HCRTR1 O43613 4/20 0.47
▸ CASP1 P29466 4/20 0.47
▸ CASP7 P55210 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NPC1 O15118 4/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ TSHR P16473 3/20 0.45
▸ USP2 O75604 2/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ POLB P06746 2/20 0.45
▸ ALOX15 P16050 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8832096 0.96 L3MBTL1 (0.48) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL9034273 0.85 MEN1 (0.53) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL16621922 0.81 MEN1 (0.68) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8832235 0.81 MEN1 (0.47) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8832521 0.80 MEN1 (0.55) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8831953 0.80 MEN1 (0.55) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8832276 0.79 KMT2A (0.64) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8832299 0.77 L3MBTL1 (0.54) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL8832095 0.74 KMT2A (0.52) L3MBTL1LMNAKMT2AMEN1NR1I2
SCHEMBL6007444 0.74 NQO2 (0.50) L3MBTL1LMNAKMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597921-A ANTITUMOR AGENTS, TREATMENT OF LEUKEMIA TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-01-28 — — US disclosed
EP-0695754-A1 INDOLO 2,3-b]QUINOXALINE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1996-02-07 — — EP disclosed
Send feedback